Сlinical analysis of the series of A-VEGF therapy in patients with retinal pigment epithelium tear complicating of wet form age-related macular degeneration

    

    Abstract

    Сlinical analysis of the series of A-VEGF therapy in patients with retinal pigment epithelium tear complicating of wet form age-related macular degeneration

    E.V. Kozina, S.N. Sakhnov, V.V. Myasnikova, E.V. Bykova

    Fyodorov Eye Microsurgery Federal State Institution, Krasnodar Branch, Russian Federation
Kuban State Medical University, Krasnodar, Russian Federation

    Purpose. Analysis A-VEGF therapy for wet form age-related macular degeneration (AMD) complicated by retinal pigment epithelium tear (RPET), different in involvement of macular zone (MZ), with different time of RPET regarding A-VEGF therapy.

    Material and methods. The results of treatment 18 patients with wet AMD complicated by RPET during monthly A-VEGF injection were analyzed. In first group (10 eyes) – RPET occurred before treatment, the second (8 eyes) – RPET arisen during A-VEGF. Visometry, ophthalmoscopy, fundus photoregistration, MZ OCT before and in month after each injection. Age – 65–83 years.

    Results. RPET (1,5 DD) captured fovea in 7 first group patients, in 3 patients RPET (0,5 DD) didn't affect fovea, In macula registered subretinal fluid (SRF) and hemorrhage (SRH). After 2 A-VEGF injections, resorption of SRF and SRH was observed. VA increased from 0,2 to 0,7 in cases RPET without capture of the fovea. RPET involving fovea occurred in 8 patients of the second group after the first A-VEGF injection. SRH and SRF resorbed. VA of patients decreased from 0,7 to 0,15. In both groups relapses of the SRF in macula after the development of RPET were not observed.

    Conclusion. Wet AMD complicated by RPET as a result of the pathological process and on the background of A-VEGF therapy. When RPET is involved fovea, VA decreases to 0.15. In case of preservation RPE in fovea – VA is high. A-VEGF therapy for wet AMD with RPET leads to resorption of SRH and SRF, to stop SRF for a long time.

    Key words: wet form macular degeneration, Anti-VEGF therapy, retinal pigment epithelium tear, macular zone

    

    For quoting: Kozina E.V., Sakhnov S.N., Myasnikova V.V., Bykova E.V. Сlinical analysis of the series of A-VEGF therapy in patients with retinal pigment epithelium tear complicating of wet form age-related macular degeneration. Fyodorov Journal of Ophthalmic Surgery. 2021;3: 89–94. https://doi.org/10.25276/0235-4160-2021-3-89-94

    

    For correspondence:

    Elena Kozina, ophthalmologist

    ORCID ID: 0000-0002-2959-9649

    E-mail: elena_eyedoc@mail.ru